Avanir Pharmaceuticals Inc.: What Investors Must Watch in 2014
A big mid-stage disappointment sent Avanir's (AVNR) shares tumbling, but the future may not be as bad as some fear.
Will Mallinckrodt's Xartemis Change How We Treat Pain?
Mallinckrodt's (MNK) pain killer drug Xartemis may give doctors a drug that's less likely to be abused than current options.
Avanir Pharmaceuticals' Revenue Soars 62% on Strong Nuedexta Sales
Avanir's loss shrinks as higher sales of PBA drug Nuedexta counter a rise in R&D and marketing costs.